Purchase Order 36C25925P0772
Award Date
6/6/25
Potential Completion Date
6/6/26
Potential Value
$79K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Natera Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78753, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) has awarded a $35,000 firm fixed-price delivery order contract to Natera Inc., a leading biotechnology company, for next-generation sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services in support of cancer research. This contract is not designated as a set-aside. Natera has been a prime contractor for the VA, providing advanced genomic testing and analysis services, including tumor whole exome sequencing, minimal residual...
This $92,391 firm-fixed-price delivery order was awarded by the U.S. Department of Veterans Affairs (VA) to Natera Inc., a leading biotechnology company specializing in advanced genomic and molecular diagnostic testing services. The contract is for minimal residual disease testing services, which support the VA's research and patient care initiatives in oncology and precision medicine. Natera has been awarded multiple federal contracts with the VA, including indefinite delivery contracts...
The U.S. Department of Veterans Affairs (VA) Headquarters awarded a new delivery order worth $499,447.00 to Natera Inc., a global leader in cell-free DNA testing. This order extends the period of performance for six months under an existing indefinite delivery contract between the VA and Natera valued at up to $6.72 million over two years. The contract is for Natera to provide minimal residual disease testing services, which analyze cell-free DNA biomarkers in patient blood samples to detect...
The Department of Veterans Affairs (VA) headquarters awarded an indefinite delivery contract to Natera Inc., doing business as Natera, for up to $6.72 million over two years. This contract covers the delivery of minimal residual disease testing services to detect remaining cancer cells in patients after initial treatment, guiding further treatment decisions. An initial delivery order worth $496,460 was issued to fund research and development activities related to this testing through Fiscal Year...
The Department of Veterans Affairs (VA) awarded a $328,300 firm-fixed price contract to Natera Inc. to provide tumor whole exome sequencing and peripheral blood circulating tumor DNA (ctDNA) testing services for a VA-funded research study on esophageal cancer patients. The contract has a base period of one year with four one-year option periods, for a total potential value of $328,300. The services include performing tumor whole exome sequencing and ctDNA testing from patient samples to...
This firm fixed-price purchase order for $84,150 was awarded by the Department of Veterans Affairs (VA) to Invitae Corporation, a for-profit genetic testing company, to provide genetic testing services in support of the VA's Million Veteran Program (MVP) and MVP-ROAR study. The contract will run from July 2020 through July 2025 and does not have a set-aside designation. Under this contract, Invitae will perform DNA sequencing, analysis, interpretation, and reporting of genetic tests for the...
This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Invitae Corporation, a for-profit genetic information company. The $39,400.00 contract is for genetic laboratory testing services to support the VA's genomic medicine program. Invitae is an experienced federal contractor, holding various blanket purchase agreements (BPAs) with the VA and Army Medical Command to provide a range of...
This is a $130,500.00 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Invitae Corporation, a genetic information company, for genetic testing services. The award is not a set-aside contract. Invitae has provided genetic testing services to various federal agencies, including the VA, National Institutes of Health, and Department of the Army, to support precision medicine, clinical research, and genomic healthcare initiatives for veterans and service...
This is a $7,900 firm fixed price purchase order award from the Department of Veterans Affairs (VA) to Invitae Corporation, doing business as Invitae, a genetic information company that provides advanced genetic diagnostics. The contract has no set-aside designation and is for the "RATIFICATION" of services. Invitae has provided a range of genetic testing services and capabilities to the VA, Army Medical Command, and other federal agencies through numerous prime contract awards,...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Invitae Corporation, doing business as Invitae, for $122,350.00 in reference laboratory testing services. The contract has a completion date of June 29, 2024 and supports genetic testing capabilities for the VA's Veterans Integrated Service Network 22 (VISN 22). Invitae provides a range of genetic testing services to VA medical facilities, including diagnostic testing, whole genome sequencing, and...